Previously treated cases tested for RR-/MDR-TB in Georgia
Georgia: Previously treated cases tested for RR-/MDR-TB was 92.0% in 2024. ▲ Rising
Previously treated cases tested for RR-/MDR-TB in Georgia, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Georgia stood at 92.0%.
The figure is up 1.1% on the previous year and up 50.8% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Georgia peaked at 100.0% in 2009 and was at its lowest, 24.0%, in 2005.
That places Georgia 79th out of 180 countries with data for 2024, putting it in the middle of the range.
The long-run direction has been consistently rising across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Georgia, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 24.0% | — |
| 2006 | 30.0% | +25.0% |
| 2007 | 30.0% | +0.0% |
| 2008 | 43.0% | +43.3% |
| 2009 | 100.0% | +132.6% |
| 2010 | 40.0% | -60.0% |
| 2011 | 52.0% | +30.0% |
| 2012 | 45.0% | -13.5% |
| 2013 | 45.0% | +0.0% |
| 2014 | 61.0% | +35.6% |
| 2015 | 64.0% | +4.9% |
| 2016 | 74.0% | +15.6% |
| 2017 | 74.0% | +0.0% |
| 2018 | 86.0% | +16.2% |
| 2019 | 93.0% | +8.1% |
| 2020 | 95.0% | +2.2% |
| 2021 | 93.0% | -2.1% |
| 2022 | 90.0% | -3.2% |
| 2023 | 91.0% | +1.1% |
| 2024 | 92.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 45.4% | 24.0% | 100.0% | 5 |
| 2010s | 63.4% | 40.0% | 93.0% | 10 |
| 2020s | 92.2% | 90.0% | 95.0% | 5 |
Countries ranked near Georgia
- 78 Mali 93.0% compare
- 79 Lebanon 92.0% compare
- 79 China (People’s Republic of) 92.0% compare
- 82 Tajikistan 91.0% compare
More health data for Georgia
- Un projection of annual infant deaths, annual growth rate -3.7 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0382 % change on previous year (2090)
- Heat deaths vs projected death rates 1,310 (2090)
- Un projection of annual infant deaths 26 (2100)
- Population ages 65 and above, female, annual growth rate 5.51 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.1036 units per person (2025)
- Population ages 65 and above, male, annual growth rate 5.68 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0563 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Georgia?
- Previously treated cases tested for rr-/mdr-tb in Georgia was 92.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Georgia?
- The highest recorded value was 100.0% in 2009.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Georgia?
- The lowest recorded value was 24.0% in 2005.
- How does Georgia rank for previously treated cases tested for rr-/mdr-tb?
- Georgia ranks 79th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Georgia?
- Over the last ten years it is up 50.8%. The long-run trend across the full record is rising.
- Where does this Georgia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).